Tenon Medical (TNON) CFO converts 1,041 RSUs into common stock holdings

Rhea-AI Filing Summary

Tenon Medical, Inc. Chief Financial Officer Kevin Williamson acquired shares through equity award activity. On March 3, 2026, 1,041 restricted stock units granted on November 5, 2024 converted into 1,041 shares of common stock. After these transactions, he directly held 43,593 common shares and 3,126 restricted stock units.

Insider Trade Summary

1,041 shares exercised/converted

Mixed 2 txns

Insider Williamson Kevin

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,041	$0.00	--
Exercise	Common Stock	1,041	$0.00	--

Holdings After Transaction: Restricted Stock Units — 3,126 shares (Direct); Common Stock — 43,593 shares (Direct)

Footnotes (1)

1. Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williamson Kevin

(Last) (First) (Middle)

104 COOPER COURT

(Street)

LOS GATOS CA 95032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/03/2026		M		1,041	A	$0	43,593	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units(1)	(2)	03/03/2026		M			1,041	(1)	(1)	Common Stock	1,041	$0	3,126	D

Explanation of Responses:

1. Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026.

2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

	/s/ Kevin Williamson	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Tenon Medical (TNON) CFO Kevin Williamson report?

Kevin Williamson reported the conversion of restricted stock units into common stock. On March 3, 2026, 1,041 restricted stock units converted into 1,041 Tenon Medical common shares, reflecting previously granted equity now settled in stock and increasing his directly held common share position.

How many Tenon Medical (TNON) shares did the CFO hold after the reported transactions?

After the March 3, 2026 transactions, CFO Kevin Williamson directly held 43,593 shares of Tenon Medical common stock. He also directly held 3,126 restricted stock units, which represent contingent rights to receive additional common shares in the future under the company's equity arrangements.

What was the nature of the restricted stock units in the Tenon Medical (TNON) Form 4 filing?

Each restricted stock unit represented a contingent right to receive one share of Tenon Medical common stock. On March 3, 2026, 1,041 of these units converted into 1,041 common shares, reflecting settlement of part of the CFO's previously granted equity-based compensation award.

When were the Tenon Medical (TNON) restricted stock units originally granted to the CFO?

The 1,041 restricted stock units that converted on March 3, 2026 were originally granted to CFO Kevin Williamson on November 5, 2024. This grant later settled into an equal number of common shares, as disclosed in the insider transaction report.

Did the Tenon Medical (TNON) Form 4 involve open-market buying or selling by the CFO?

The Form 4 describes an exercise or conversion of derivative securities, not an open-market trade. 1,041 restricted stock units converted into 1,041 common shares at a stated price of $0.0000 per share, consistent with equity award settlement rather than market purchases or sales.